Mulligan Richard
SEC-identified person · CIK 1376247 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sana Biotechnology, Inc. SANA | Director · Head of SanaX | filed 2021 - 2026 |
| International Flavors & Fragrances INC IFF | Director | filed 2025 - 2026 |
| Valeant Pharmaceuticals International, Inc. vrx | Director | filed 2022 - 2025 |
| Biogen INC. BIIB | Director | filed 2009 - 2022 |
| Viskase Holdings, Inc. ENZND | Director | filed 2009 - 2013 |
| Imclone Systems INC/DE IMCL | Director | filed 2006 - 2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.